Markets:

Overview

News

Currencies

International

Treasuries

Cardiol Therapeutics Inc. - Class A Common Shares (NQ:CRDL)

1.359 -0.001 (-0.08%)

Streaming Delayed Price Updated: 9:44 AM EDT, Aug 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Cardiol Therapeutics Inc. - Class A Common Shares

< Previous 1 2 Next >

On Tuesday, there are stocks with unusual volume. Let's take a look. ↗

March 31, 2026

Via Chartmill

This Visa Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

June 02, 2025

Via Benzinga

3 Penny Stocks Ready to Break Out in 2025

November 29, 2024

Vuzix, GeoVox Labs, and Cardiol Therapeutics emerged as notable penny stocks late in 2024 for their potential to scale operations and launch new products.

Via MarketBeat

CBD-Based Drug Reduces Pericarditis Pain And Inflammation, Shows New Clinical Study ↗

November 19, 2024

Via Benzinga

Why Cardiol Therapeutics (CRDL) Stock Is Down 20% Today ↗

October 09, 2024

Cardiol Therapeutics shares are trading lower by 20% Wednesday morning. The company announced a $13.5 million public offering.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

October 19, 2022

On Wednesday, 200 companies hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

March 11, 2022

During Friday's session, 198 companies made new 52-week lows. Key Facts About Today's 52-Week Highs And Lows: Alibaba Group Holding (NYSE:BABA) is the largest...

Via Benzinga

AZZ, Helen of Troy And 3 Stocks To Watch Heading Into Wednesday ↗

October 09, 2024

Via Benzinga

CRDL Stock Earnings: Cardiol Therapeutics Beats EPS for Q2 2024 ↗

August 12, 2024

CRDL stock results show that Cardiol Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Hope on the Horizon: Results from MAvERIC-Pilot Show Heartfelt Progress for Patients

June 17, 2024

Hope on the Horizon: Results from MAvERIC-Pilot Show Heartfelt Progress for Patients

Via News Direct

Analysts’ Consensus Reaffirms Significant Upside Potential for Cardiol Therapeutics

May 28, 2024

Analysts’ Consensus Reaffirms Significant Upside Potential for Cardiol Therapeutics

Via News Direct

CRDL Stock Earnings: Cardiol Therapeutics Meets EPS for Q1 2024 ↗

May 14, 2024

CRDL stock results show that Cardiol Therapeutics met analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In ↗

May 14, 2024

Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028.

Via Benzinga

Topics Cannabis

CRDL Stock Earnings: Cardiol Therapeutics Beats EPS for Q4 2023 ↗

April 02, 2024

CRDL stock results show that Cardiol Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Cardiol Therapeutics - This Penny Stock Is An Analysts Favorite ↗

January 31, 2024

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies.

Via Talk Markets

Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases

October 13, 2023

--News Direct--

Via News Direct

Topics Death

Cardiol Therapeutics Fights Heart Inflammation With Novel Formulations ↗

October 12, 2023

697,000 people die from heart disease every year in the United States – that is one in every five deaths.

Via Benzinga

CBD To Treat Heart Failure? New Study Shows Its Cardioprotective Effects ↗

October 10, 2023

On Tuesday, Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) announced positive study results demonstrating that subcutaneously administered cannabidiol - the active pharmaceutical ingredient in...

Via Benzinga

Why Murphy Canyon Acquisition Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket ↗

September 21, 2023

Gainers Near Intelligence, Inc. (NASDAQ: NIR) shares rose 34.1% to $0.2801 in pre-market trading after falling 42% on Wednesday. Near Intelligence recently named its General Counsel, Jay Angelo, to...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

October 04, 2022

On Tuesday, 44 companies hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

October 18, 2022

During Tuesday's session, 78 companies made new 52-week lows.

Via Benzinga

FDA Clears Cardiol Therapeutics' IND for CardiolRx in Recurrent Pericarditis ↗

May 17, 2022

The U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug Application (IND) from Cardiol Therapeutics Inc. (NASDAQ: CRDL) to start a Phase 2 open-label pilot study designed...

Via Benzinga

76 Biggest Movers From Yesterday ↗

May 19, 2022

Gainers Bright Green Corp. (NASDAQ: BGXX) jumped 90.5% to close at $48.08 on Wednesday. Bright Green Corporation, went public on the NASDAQ Tuesday, becoming the first U.S. plant-touching company to...

Via Benzinga

34 Stocks Moving In Monday's Mid-Day Session ↗

April 18, 2022

Gainers Casa Systems, Inc. (NASDAQ: CASA) shares climbed 66.3% to $6.47 after the company announced a multi-year contract with Verizon to provide 5G core network functions....

Via Benzinga

68 Biggest Movers From Yesterday ↗

April 19, 2022

Gainers Casa Systems, Inc. (NASDAQ: CASA) shares surged 82.5% to close at $7.10 on Monday after the company announced a multi-year contract with Verizon to provide 5G core...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2022 ↗

March 17, 2022

Upgrades Loop Capital upgraded the previous rating for Aspen Technology Inc (NASDAQ:AZPN) from Hold to Buy. In the second quarter, Aspen Technology showed an EPS of $1.20,...

Via Benzinga

51 Biggest Movers From Thursday ↗

April 18, 2022

Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 69.4% to close at $2.44 on Thursday. Ally Bridge Group recently reported a purchase of 21.176 million shares of...

Via Benzinga

Cardiol Therapeutics To Include Vaccinated Participants In Cannabidiol COVID-19 Trial ↗

March 01, 2022

The FDA and regulatory agencies in Brazil & Mexico have cleared Cardiol Therapeutics Inc (NASDAQ: CRDL) to modify the inclusion criteria for the LANCER trial to...

Via Benzinga

52 Biggest Movers From Yesterday ↗

January 20, 2022

Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares surged 65.7% to close at $25.92 on Wednesday after the company announced it will be acquired by UCB for approximately $1.9 billion. G...

Via Benzinga

65 Biggest Movers From Yesterday ↗

January 19, 2022

Gainers Brickell Biotech, Inc. (NASDAQ: BBI) shares jumped 58.6% to settle at $0.33 on Tuesday after HC Wainwright & Co initiated coverage on the stock with a Buy rating and...

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Cardiol Therapeutics Inc. - Class A Common Shares (NQ:CRDL)

Headline News about Cardiol Therapeutics Inc. - Class A Common Shares

Starting at /week.